Sagimet Biosciences Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Sagimet Biosciences Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q2 2024.
Sagimet Biosciences Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $151K, a 4.86% increase year-over-year.

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$151K	+$7K	+4.86%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$37K			Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$73K	-$139K	-65.6%	Dec 31, 2023	10-Q	2024-08-14
Q3 2023	$109K			Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$144K			Jun 30, 2023	10-Q	2023-08-21
Q4 2022	$212K			Dec 31, 2022	10-K	2024-03-25

* An asterisk sign (*) next to the value indicates that the value is likely invalid.